Raymond James Increases DexCom (NASDAQ:DXCM) Price Target to

DexCom (NASDAQ:DXCM – Get Free Report) had its target price lifted by research analysts at Raymond James from $151.00 to $160.00 in a research report issued on Friday, Benzinga reports. The brokerage currently has a “strong-buy” rating on the medical device company’s stock. Raymond James’ price target points to a potential upside of 28.68% from […]

Related Keywords

Canada , United States , Raymond James , Kevinr Sayer , Raymond Jame , Capital Partners , Royal Bank , Citigroup , Dexcom Inc , Canaccord Genuity Group , Smithfield Trust Co , Securities Exchange Commission , Nasdaq , Riverview Trust Co , Mv Capital Management Inc , Valley National Advisers Inc , Dexcom Company Profile , Get Free Report , Genuity Group , Exchange Commission , National Advisers , Dexcom Share , Dexcom Real Time , Dexcom Daily , Dexcom , Nasdaq Dxcm , Dxcm , Medical , 25213110 , Boost Price Target ,